Patent · US Expired

HIV integrase inhibitors

US7109186B2 · kind B2 · utility

15Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 9, 2003
Grant dateSep 19, 2006
Priority date
Expiry dateMar 2, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention describes novel compounds of Formula I which inhibit HIV integrase. The invention also describes compositions and treatments of AIDS or ARC by using these compounds

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.